Deals
Option Care Health Withdraws Its Forecast And Cancels Its Call As Buyout Looms
The infusion provider's third-quarter profit rose to $0.38 a share, but it dropped guidance with Clayton, Dubilier & Rice and McKesson set to buy it.
Option Care Health (OPCH) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Deals
The infusion provider's third-quarter profit rose to $0.38 a share, but it dropped guidance with Clayton, Dubilier & Rice and McKesson set to buy it.
Markets
The deal values the home-infusion company at about $5.8 billion, with a $145,963,976 fee if Option Care Health walks away in specified cases.